Table 3. Studies of serrated polyps and smoking.
Author, year | Study description | n with SPs | Smoking* OR/RR† (95% CI) |
---|---|---|---|
All SPs | |||
Kearney, 1995 [44] | US population (NHS/HPFS) Screening sigmoidoscopy or colonoscopy, distal HP/SP only | 394 | |
Martinez, 1997 [41] | US population (TX) Screening sigmoidoscopy or colonoscopy | 81 | |
Erhardt, 2002 [42] | German population Screening/diagnostic colonoscopy | 71 | Ever smoker: 1.79 (1.04-3.06) |
Morimoto, 2002 [45] | US population (MN) Screening/diagnostic colonoscopy | 219 | Former smoker: 2.5 (1.4-4.4) Current smoker: 4.1 (2.2-7.6) |
Lieberman, 2003 [33] | US population (veterans) Screening colonoscopy | 391 | Former smoker: 1.65 (1.23-2.23) Current smoker: 2.71 (1.93-3.81) |
Ji, 2006 [43] | US population (PLCO) Screening sigmoidoscopy, distal HP/SP only | 1545 | Former smoker: 1.8 (1.6-2.1) Current smoker: 4.4 (3.7-5.2) Ever smoker: 2.1 (1.9-2.4) |
Omata, 2009 [46] | Japanese population Diagnostic colonoscopy | 132 | |
Fu, 2012 [60] | US population (TN) Screening/diagnostic colonoscopy | 662 | Former smoker: 1.93 (1.56-2.38) Current smoker: 4.44 (3.47-5.67) <30 pack-years: 4.74 (3.51-6.42) ≥30 pack-years: 4.04 (3.02-5.42) |
Burnett-Hartman, 2013 [48] | US population (Group Health, WA) Screening colonoscopy | 594 | Former smoker: 1.70 (1.34-2.16) Current smoker: 3.00 (1.93-4.66) |
Proximal/large SPs | |||
Wallace, 2009 [52] | US population (multicenter/PPSG) Proximal SPs | 261 | Former smoker: 0.98 (0.75-1.28) Current smoker: 1.11 (0.80-1.54) |
Bouwens, 2013 [51] | Dutch population Proximal, large (>6mm) or dysplastic SPs | 141 | |
Burnett-Hartman, 2013 [48] | US population (Group Health, WA) Proximal SPs | 199 | Former smoker: 1.16 (0.79-1.71) Current smoker: 0.88 (0.32-2.39) |
SSAs | |||
Anderson, 2011 [49] | US population (CT) Pancolonic SSAs | 90 | |
Burnett-Hartman, 2013 [48] | US population (Group Health, WA) Pancolonic SSAs | 149 |
Referent category (OR/RR=1.0) is nonsmokers or never smokers for all studies unless otherwise stated
multivariate adjusted OR reported when provided
SP: serrated polyp; SSA: sessile serrated adenoma; OR: odds ratio; RR: risk ratio; CI: confidence interval; NHS/HPFS: Nurses Health Study/Health Professionals Followup Study; PLCO: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; PPSG: Polyp Prevention study Group
Red text: statistically significant result